Position in NVO
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$193,251,605
+$47,742,553 QoQ
Shares Held
4,031,114
+1.8% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#20
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ENVESTNET ASSET MANAGEMENT INC holds $6,826,194,566 across 15 Drug Manufacturers - General names. NVO ranks #10 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,175,866 | $1,410,369,073 | |
| 2 | JNJ |
Johnson & Johnson
|
4,910,996 | $1,247,245,654 | |
| 3 | ABBV |
AbbVie Inc.
|
4,886,670 | $1,229,681,638 | |
| 4 | AMGN |
Amgen Inc
|
1,689,843 | $611,925,947 | |
| 5 | MRK |
Merck & Co., Inc.
|
3,996,890 | $513,600,365 | |
| 6 | AZN |
Astrazeneca PLC
|
2,281,431 | $432,604,946 | |
| 7 | NVS |
Novartis AG
|
2,330,979 | $365,311,028 | |
| 8 | PFE |
Pfizer Inc
|
9,513,242 | $229,078,867 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $193,251,605 | 4,031,114 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $145,509,052 | 3,959,430 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $141,112,321 | 2,773,434 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $217,720,619 | 3,923,601 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $288,896,323 | 4,185,690 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $311,890,732 | 4,491,514 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $358,504,091 | 4,167,683 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $509,460,046 | 4,278,660 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $607,241,653 | 4,254,180 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $538,669,458 | 4,195,245 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $435,936,024 | 4,213,978 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $414,002,622 | 4,552,481 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $286,862,285 | 1,772,615 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $844,852,935 | 5,308,866 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $239,770,780 | 1,771,618 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $179,778,947 | 1,804,466 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $201,424,322 | 1,807,631 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $178,083,444 | 1,603,633 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $158,761,232 | 1,417,511 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $128,842,827 | 1,341,973 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $108,887,010 | 1,299,833 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $84,204,613 | 1,248,956 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $81,877,471 | 1,172,190 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $80,324,400 | 1,156,912 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $76,319,362 | 1,165,537 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $67,832,216 | 1,126,781 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||